Artivion | CRY - Операционные расходы

Биржевая цена
37.04
Изменение за день
-0.82 -2.17%
Ежемесячно
-6.49%
Ежегодный
53.18%
Q1 прогноз
35.91




Операционные расходы Изменить Дата
Abbott USD 9.21B 17M 2025-12
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.98M 1.96M 2025-02
Artivion USD 56.62M 195K 2024-09
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Inogen USD 49.14M 665K 2024-09
Integra LifeSciences USD 368.92M 668.65M 2025-12
J&J USD 18.97B 2.38B 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Orthofix International USD 10.89M 209.57M 2024-09
Pfizer USD 12.91B 79.89B 2025-12
ResMed USD 925.21M 51.98M 2025-12
Stryker USD 5.2B 505M 2025-12
Surmodics USD -245.35M 363.49M 2024-09
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Trinity Biotech USD 14.82M 7.81M 2025-09